Skip to main content
Clinical Trials/NCT01400711
NCT01400711CompletedNot Applicable

Enhanced Recovery After Surgery (ERAS) Versus Conventional Postoperative Care in Patients Undergoing Major Intra-abdominal Surgery.

St. Andrew's General Hospital, Patras, Greece2 sites in 1 country54 target enrollmentStarted: October 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
54
Locations
2
Primary Endpoint
Morbidity.

Study Overview

Brief Summary

Enhanced Recovery After Surgery (ERAS) programs have been introduced with aims of attenuating the stress response to surgery and enabling rapid recovery. There is strong evidence of the usefulness of the ERAS programs in patients undergoing colorectal surgery in terms of significantly reduced postoperative complications and shorter length of hospital stay, compared to the patients of traditional treatment. However, few studies exist about the implication of ERAS programs in major upper abdominal surgery patients.

The aim of this study was to compare morbidity, mortality and length of stay in patients undergoing major intrabdominal surgery, including upper and lower gastrointestinal, receiving either conventional postoperative care or an ERAS program.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 89 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Elective surgery
  • ASA grade < 4

Exclusion Criteria

  • Emergency surgery
  • ASA grade > 3

Arms & Interventions

Control patients

Active Comparator

Patients planned to undergo major intrabdominal surgery, following the conventional perioperative care.

Intervention: Traditional (Other)

ERAS patients

Active Comparator

Patients planned to undergoing major intrabdominal surgery, following the ERAS perioperative care.

Intervention: ERAS perioperative care (Other)

Outcomes

Primary Outcomes

Morbidity.

Time Frame: 30 days after surgery

Secondary Outcomes

  • Mortality.(30 days after surgery)

Investigators

Sponsor
St. Andrew's General Hospital, Patras, Greece
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials